Every 424B that PMGC Holdings Inc. (ELAB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow ELAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ELAB filings page.
PMGC Holdings Inc. is registering $7,793,112 of Common Stock for issuance and resale related to a Purchase Agreement with Streeterville Capital, LLC. The transaction includes 262,467 Registered Shares delivered for $1,000,000 and additional Pre-Paid Purchase Shares equal to $6,793,112 of remaining shelf capacity. The Purchase Agreement contemplates an equity purchase facility (ELOC) of up to $40,000,000 and a computed Pre-Paid Purchase price of $10,000,000 (after an OID and transaction expenses). The Company received net proceeds of $9,727,380 at consummation and agreed to a placement fee of 8.0% to Univest. The prospectus supplement also notes management’s going-concern uncertainty as of the latest fiscal year-end.
PMGC Holdings Inc. is registering up to $4,551,804 of common stock as part of an equity purchase facility (ELOC) with Streeterville Capital, LLC. The Purchase Agreement contemplates up to $20,000,000 of purchases via prepaid tranches; four prepaid purchases were consummated between Sept 23, 2025 and Feb 6, 2026. Shares issued to the Investor may be sold by the Investor from time to time; Univest Securities is the placement agent and receives an 8% fee. The company discloses a going concern uncertainty as of Dec 31, 2025 and lists recent corporate actions including a 1-for-6 reverse split, the acquisition of SVM Machining, and a license of biotech assets for non-human animal health.
PMGC Holdings Inc. is registering and offering up to $1,222,168 of its common stock under a shelf registration, selling shares directly to Streeterville Capital through an equity line of credit structure. Shares will be issued against pre-paid purchase balances at a discount to recent volume‑weighted average prices.
The company has used multiple pre-paid purchases to raise cash and faces substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $18,034,757 as of September 30, 2025 and recurring net losses. Management plans to use net proceeds for general corporate purposes and potential acquisitions, which are not yet identified, and warns that further issuances under the equity facility and other derivative securities could significantly dilute existing shareholders and pressure the Nasdaq‑listed stock price.
PMGC Holdings Inc. is offering $5,464,500 of common stock to Streeterville Capital under a pre-paid equity purchase facility, with an initial purchase price of $5,000,000 for the Third Pre-Paid Purchase before fees and expenses. This prospectus supplement also covers resale of the shares by Streeterville to the public as an underwriter. The equity line totals up to $20,000,000 across multiple pre-paid purchases, each discounted to 88% of the lowest 10-day VWAP, subject to floor prices and a 9.99% ownership cap. PMGC previously completed two pre-paid purchases and a separate S-1 registering up to 5,000,000 resale shares. The company effected a 1-for-4 reverse stock split and increased authorized common stock to 2,000,000,000 shares. As of late 2024 and 2025, it reported recurring net losses, substantial accumulated deficits and a going-concern warning, and plans to use proceeds for general corporate purposes and potential acquisitions.
PMGC Holdings Inc. is registering up to 5,000,000 shares of common stock for resale by Streeterville Capital and other selling security holders under a pre-paid equity purchase financing. These include 56,700 commitment shares, 10,300 pre-delivery shares, and up to 4,933,000 shares issuable over time under current and future pre-paid purchases. The company is not selling shares in this offering and will receive no proceeds from resales, though it previously received $3.99M net from an initial $5.0M pre-paid purchase and may receive up to $20M in aggregate gross proceeds if it draws the full facility. Shares of common stock outstanding were 744,121 before this offering and would be 5,677,121 if all registered shares are issued. The filing highlights substantial doubt about the company’s ability to continue as a going concern, a history of losses, significant potential dilution, and voting control of about 81.11% held via Series B preferred stock by affiliates of its chairman and chief executive officer.
PMGC Holdings Inc. is registering up to 236,543 shares of common stock for resale, all issuable upon exercise of previously issued common stock purchase warrants. The company will not receive proceeds from any resale of these shares by the selling shareholders, but could receive approximately $1.56 million if all such warrants are exercised for cash.
PMGC is a diversified holding company with biotechnology, specialty packaging and precision machining subsidiaries, and has recently divested its prior Elevai Skincare business to focus on larger market opportunities. It has also put in place a $20 million secured equity line, completed the acquisitions of AGA Precision Systems LLC for $650,000 in cash and Pacific Sun Packaging, Inc. for $1,148,000 in cash plus up to $250,000 in earnout, and adopted a 2025 equity incentive plan while increasing authorized common stock to 2,000,000,000 shares.
The company reports recurring losses and an accumulated deficit of $18,034,757 as of September 30, 2025, with management stating there is substantial doubt about its ability to continue as a going concern and highlighting the need for additional debt or equity financing. Existing preferred stock held by entities owned by its chairman and CEO currently controls about 89.55% of voting power, and the filing emphasizes significant dilution and resale overhang risks from warrants, equity facilities and future plan issuances.